Heborium Group Announces 23% Increase in 1st Quarter 2012 Revenue Social Media Campaign brings significant increase in Internet sales

TEANECK, N.J., March 8, 2012 /PRNewswire/ -- Herborium Group, Inc. (HBRM.PK) www.herborium.com,  is pleased to announce  today that the Company' Internet sales  for first quarter of 2012 grew 23% in comparison  to the same quarter of 2011.

"During the Summer of 2011 we initiated  an new and aggressive Social Media Marketing Strategy  to build awareness of our brand and increase our sales.  We are  very pleased to confirm that this strategy is indeed bringing expected results as our Internet sales for  the first  quarter of 2012  increased 23 %  in comparison to the same quarter of the last year" stated  Dr. Agnes P. Olszewski, CEO of Herborium Group. Inc.

"Our initiatives placed Herborium and our star Botanical Therapeutic® for treatment of symptoms of Acne  on Tyra Banks website  to reach the women of color market, on www.myskin.com  to access the upscale women beauty and health market  and on  HealthandBeautyProject com natural health platform, between others  We have many more new and powerful initiatives involving  Social Media coming up and we will share them with our investors over time."  Concluded Dr. Olszewski .   

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals.  The Company uses clinical validation to establish and maintain a differential advantage. The company sales its products in the US and Europe. For more information, please visit www.herborium.com and www.acnease.com. 

One of our most important responsibilities is to communicate with shareholders in an open and direct manner.  Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends."  We cannot promise future returns.  Our statements reflect our best judgment at the time, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events.  The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.

For more information please inquire: Investorsrelations@herborium.com